TScan Therapeutics Reorganizes to Focus on In Vivo TCR-T Cell Therapy for Solid Tumors
Waltham, Mass., September 2, 2026 TScan Therapeutics, Inc. announced a strategic reorganization to prioritize its in vivo-engineered TCR-T cell...
Cell Therapy
Advertisement
FibroBiologics Secures U.S. Patent for Disc Regeneration
Houston, Texas, September 1, 2026 FibroBiologics, Inc. has announced the issuance of a new U.S. patent covering a potential...
Resolution Therapeutics Expands U.S. Access for RTX001
EDINBURGH, UK & LONDON, UK, Sept. 1, 2026 Resolution Therapeutics Limited has partnered with Blood Centers of America, Inc....
Adicet Bio Advances Prula-Cel Toward SLE Data Readout
REDWOOD CITY, Calif., September 1, 2026 Adicet Bio announced completion of the last patient visit for the planned Phase...
CREATE Medicines, WestGene Expand In Vivo CAR Programs
CAMBRIDGE, Mass., U.S., Aug 28, 2026 CREATE Medicines, Inc. announced a strategic research and development collaboration and license agreement...
Advertisements
Celularity and MuseCell Innovations Announce U.S. Manufacturing Collaboration
Florham Park, New Jersey & Singapore – August 28, 2026 Celularity Inc. announced a new U.S.-based manufacturing collaboration with...
Gilead Wins FDA Approval for Bixlenvo HIV Single Tablet
FOSTER CITY, Calif. – August 27, 2026 Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA)...
Adicet Bio Gains FDA Clearance for ADI-212 IND in mCRPC
REDWOOD CITY, Calif. – August 27, 2026 Adicet Bio, Inc. announced that the U.S. Food and Drug Administration (FDA)...
4basebio and Genezen Expand Synthetic DNA Collaboration
CAMBRIDGE, UK and INDIANAPOLIS, IN — August 26, 2026 4basebio PLC and Genezen announced an expanded, non-exclusive strategic collaboration...
Cellenkos Wins FDA Fast Track for CK0803 in ALS
Houston, Texas, Aug 27, 2026 Cellenkos, Inc. has received FDA Fast Track designation for CK0803, an investigational allogeneic, cord...
Advertisement
